Page 200 - 80 guidelines for the treatment of malaria_opt

nd
Guidelines for the treatment of malaria – 2 edition

75. Tjitra E. Randomized comparative study of the therapeutic efficacy of chloroquine alone
versus combined chloroquine plus sulphadoxine-pyrimethamine and amodiaquine alone
for the treatment of vivax malaria in Bangka island, Indonesia (report of the WHO funded
study). Jarkarta, National Institute of Health Research and Development, Ministry of
Health, Indonesia, 2003.
76. da Silva RS et al. Short course schemes for vivax malaria treatment. Revista Sociedade
Brasileira de Medicina Tropical, 2003, 36:235–239.
77. Fryauff DJ et al. Halofantrine and primaquine for radical cure of malaria in Irian Jaya,
Indonesia. Annals of Tropical Medicine and Parasitology, 1997, 91:7–16.
78. Valibayov A et al. Clinical efficacy of chloroquine followed by primaquine for Plasmodium
vivax treatment in Azerbaijan. Acta Tropica, 2003, 88:99–102.
79. Baird JK et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of
recurrence and whole blood chloroquine levels. American Journal of Tropical Medicine
and Hygiene, 1997, 56:621–626.
80. Rowland M. Durrani N. Randomized controlled trials of 5- and 14-days primaquine therapy
against relapses of vivax malaria in an Afghan refugee settlement in Pakistan. Transactions
of the Royal Society of Tropical Medicine and Hygiene, 1999, 93:641–643.
81. Dua VK, Sharma VP. Plasmodium vivax relapses after 5 days of primaquine treatment, in
some industrial complexes of India. Annals of Tropical Medicine and Parasitology, 2001,
95:655–659.
82. Adak T, Sharma VP, Orlov VS. Studies on the Plasmodium vivax relapse pattern in Delhi,
India. American Journal of Tropical Medicine and Hygiene, 1998, 59:175–179.
83. Kitchener SJ, Auliff AM, Rieckmann KH. Malaria in the Australian Defense Force during
and after participation in the International Force in East Timor (INTERFET). Medical
Journal of Australia, 2000, 173:583–585.
84. Duarte EC et al. Association of subtherapeutic dosages of a standard drug regimen with
failures in preventing relapses of vivax malaria. American Journal of Tropical Medicine and
Hygiene, 2001, 65:471–476.
85. Durante ME et al. Case report: an unusual late relapse of Plasmodium vivax malaria.
American Journal of Tropical Medicine and Hygiene, 2003, 68:159–160.
86. Pukrittayakamee S et al. Therapeutic responses to antimalarial and antibacterial drugs in
vivax malaria. Acta Tropica, 2004, 89: 351–356.
87. White NJ. The assessment of antimalarial drug efficacy. Trends in Parasitology, 2002,
18:458–464.
88. Goller JL et al. Regional differences in the response of Plasmodium vivax malaria to
primaquine as anti-relapse therapy. American Journal of Tropical Medicine and Hygiene,
2007, 76:203–207.
89. Congpuong K et al. Sensitivity of Plasmodium vivax to chloroquine in Sa Kaeo Province,
Thailand. Acta Tropica, 2002, 83:117–121.
90. Wilairatana P et al. Efficacy of primaquine regimens for primaquine-resistant Plasmodium
vivax malaria in Thailand. American Journal of Tropical Medicine and Hygiene, 1999,
61:973–977.

186